Literature DB >> 7615962

Focal adhesion kinase (p125FAK) expression correlates with motility of human melanoma cell lines.

T Akasaka1, R L van Leeuwen, I G Yoshinaga, M C Mihm, H R Byers.   

Abstract

Focal adhesion kinase (p125FAK), a recently characterized protein localized within focal adhesion plaques, is believed to play a role in extracellular matrix-integrin-mediated signal transduction involving cytoskeletal proteins. We studied p125FAK expression, distribution, and relation to cell migration in six human melanoma cell lines. Western blot analysis detected differential expression of p125FAK among these lines that was directly proportional to the amount of phosphorylated p125FAK. Time-lapse image analysis of the cell lines exhibited 10-fold differences in the mean migration rates on fibronectin-coated substrates. Regression analysis revealed that p125FAK expression correlated significantly with mean migration rate in the six melanoma lines tested. Double immunofluorescent labeling for p125FAK and actin in these lines demonstrated p125FAK plaques that were localized to actin stress-fiber termination sites in the periphery of cells. The number of p125FAK plaques in the melanoma cell lines was heterogeneous, but the cell lines with more p125FAK plaques per cell exhibited significantly higher mean migration rates on fibronectin as compared with cell lines with fewer p125FAK plaques per cell. The findings support the hypothesis that focal adhesion tyrosine kinase modulates cytoskeletal function during melanoma cell migration on fibronectin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615962     DOI: 10.1111/1523-1747.ep12313396

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  20 in total

Review 1.  Integrin signaling and mammary cell function.

Authors:  Franziska Schatzmann; Rebecca Marlow; Charles H Streuli
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

2.  Phosphorylation of focal adhesion kinase at Tyr397 in gastric carcinomas and its clinical significance.

Authors:  I-Rue Lai; Pei-Yu Chu; Hsiao-Sheng Lin; Jun-Yang Liou; Yee-Jee Jan; Jen-Chieh Lee; Tang-Long Shen
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

Review 3.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

4.  Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation.

Authors:  A Richardson; R K Malik; J D Hildebrand; J T Parsons
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

5.  The interaction of activated integrin lymphocyte function-associated antigen 1 with ligand intercellular adhesion molecule 1 induces activation and redistribution of focal adhesion kinase and proline-rich tyrosine kinase 2 in T lymphocytes.

Authors:  J L Rodríguez-Fernández; M Gómez; A Luque; N Hogg; F Sánchez-Madrid; C Cabañas
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

6.  Pro-prion binds filamin A, facilitating its interaction with integrin beta1, and contributes to melanomagenesis.

Authors:  Chaoyang Li; Shuiliang Yu; Fumihiko Nakamura; Olli T Pentikäinen; Neena Singh; Shaoman Yin; Wei Xin; Man-Sun Sy
Journal:  J Biol Chem       Date:  2010-07-21       Impact factor: 5.157

7.  The protrusive phase and full development of integrin-dependent adhesions in colon epithelial cells require FAK- and ERK-mediated actin spike formation: deregulation in cancer cells.

Authors:  V G Brunton; V J Fincham; G W McLean; S J Winder; C Paraskeva; J F Marshall; M C Frame
Journal:  Neoplasia       Date:  2001 May-Jun       Impact factor: 5.715

8.  A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells.

Authors:  Elena Kurenova; Deniz Ucar; Jianqun Liao; Michael Yemma; Priyanka Gogate; Wiam Bshara; Ulas Sunar; Mukund Seshadri; Steven N Hochwald; William G Cance
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Antitumor effects of the flavone chalcone: inhibition of invasion and migration through the FAK/JNK signaling pathway in human gastric adenocarcinoma AGS cells.

Authors:  Su-Hsuan Lin; Yuan-Wei Shih
Journal:  Mol Cell Biochem       Date:  2014-02-09       Impact factor: 3.396

10.  Focal adhesion kinase as an immunotherapeutic target.

Authors:  Hiroya Kobayashi; Makoto Azumi; Yuka Kimura; Keisuke Sato; Naoko Aoki; Shoji Kimura; Masaru Honma; Hajime Iizuka; Masatoshi Tateno; Esteban Celis
Journal:  Cancer Immunol Immunother       Date:  2008-10-22       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.